Geisbrecht B V, Liang X, Morrell J C, Schulz H, Gould S J
Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Biol Chem. 1999 Sep 3;274(36):25814-20. doi: 10.1074/jbc.274.36.25814.
Here we describe the identification and characterization of a novel mouse gene, PDCR, that encodes a peroxisomal Delta(2), Delta(4)-dienoyl-CoA reductase. The mouse PDCR cDNA contains an 892-base pair open reading frame and is predicted to encode a 292-amino acid protein with a deduced molecular mass of 31,298 Da that terminates in a consensus type-1 peroxisomal targeting signal. Purified recombinant PDCR protein was generated from Escherichia coli and catalyzed the NADPH-dependent reduction of Delta(2)-trans, Delta(4)-trans-decadienoyl-CoA with a specific activity of 20 units/mg. Enzymatic characterization followed by high pressure liquid chromatography analysis of the products revealed that PDCR converted Delta(2)-trans,Delta(4)-trans-decadienoyl-CoA to a Delta(3)-enoyl-CoA but not to a Delta(2)-enoyl-CoA. Kinetic analyses demonstrated that PDCR is active on a broad range of Delta(2), Delta(4)-dienoyl-CoAs. Although the observed substrate preference was to Delta(2)-trans,Delta(4)-trans-decadienoyl-CoA, PDCR was also active on a C(22) substrate with multiple unsaturations, a result consistent with the role of peroxisomes in the oxidation of complex, very long chain, polyunsaturated fatty acids. The presence of a type-1 peroxisomal targeting signal Ala-Lys-Leu-COOH at the C terminus of PDCR suggested that this protein may be peroxisomal. We observed that tagged PDCR was efficiently transported to the peroxisome lumen in normal human fibroblasts but not in cells derived from a Zellweger syndrome patient with a specific defect in peroxisomal matrix protein import. We conclude that this protein resides within the peroxisome matrix and therefore represents the first mammalian peroxisomal Delta(2),Delta(4)-dienoyl-CoA reductase to be characterized at the molecular level.
在此,我们描述了一个新的小鼠基因PDCR的鉴定和特征,该基因编码一种过氧化物酶体Δ(2),Δ(4)-二烯酰辅酶A还原酶。小鼠PDCR cDNA包含一个892个碱基对的开放阅读框,预计编码一个292个氨基酸的蛋白质,推导分子量为31,298 Da,其C末端为一个共有型1过氧化物酶体靶向信号。从大肠杆菌中产生了纯化的重组PDCR蛋白,该蛋白催化NADPH依赖的Δ(2)-反式,Δ(4)-反式-癸二烯酰辅酶A的还原,比活性为20单位/毫克。酶学特征分析以及产物的高压液相色谱分析表明,PDCR将Δ(2)-反式,Δ(4)-反式-癸二烯酰辅酶A转化为Δ(3)-烯酰辅酶A,而不是转化为Δ(2)-烯酰辅酶A。动力学分析表明,PDCR对多种Δ(2),Δ(4)-二烯酰辅酶A具有活性。尽管观察到的底物偏好是Δ(2)-反式,Δ(4)-反式-癸二烯酰辅酶A,但PDCR对具有多个不饱和键的C(22)底物也有活性,这一结果与过氧化物酶体在复杂的、非常长链的多不饱和脂肪酸氧化中的作用一致。PDCR C末端存在一个1型过氧化物酶体靶向信号Ala-Lys-Leu-COOH,表明该蛋白可能位于过氧化物酶体中。我们观察到,带有标签的PDCR在正常人成纤维细胞中能有效地转运到过氧化物酶体腔中,但在来自患有过氧化物酶体基质蛋白导入特异性缺陷的 Zellweger 综合征患者的细胞中则不能。我们得出结论,该蛋白位于过氧化物酶体基质中,因此代表了第一个在分子水平上得到表征的哺乳动物过氧化物酶体Δ(2),Δ(4)-二烯酰辅酶A还原酶